Phreesia Inc. (NYSE:PHR) stock is moving lower in premarket trading on Tuesday following an earnings report that underscored a weaker-than-expected revenue outlook.
Phreesia Sees Weaker Pharma Spending Visibility
Phreesia on Monday lowered its fiscal 2027 revenue outlook to $510–$520 million, down from $545–$559 million, citing reduced visibility into pharma client spending and weaker-than-expected commitments for the second half of the year.
Some clients are allocating fewer dollars due to brand-specific factors, including regulatory impacts.
Management does not view this as a structural demand shift but flagged increased variability in network solutions revenue, particularly in the back half. The outlook assumes around $37 million from AccessOne and excludes any future acquisitions.
The company maintained its Adjusted EBITDA guidance at $125–$135 …
This post was originally published here
